These functions help GLP-1 agonist medications reduce high blood sugar (hyperglycemia) in people with type 2 diabetes
Syringe Units = Desired Dose (mg)Concentration (mg/mL) 100 Example: a 0.5 mg dose at 5 mg/mL = (0.5 5) 100 = 10 units
If you are at a stable maintenance dose of 1.7 mg or higher and want minimal injection volume, 10 mg/mL delivers your dose in the smallest possible volume
They can make sure youre taking the right dose
We pay special attention to any history of medical conditions, such as medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, to ensure patient safety
A biochemical and chemical technology, applied in the field of recombinant polypeptide preparation, can solve the problems of low yield, unfriendly environment and high cost Pending Publication Date: 2021-08-20 View PDF1 Cites 2 Cited by Summary Abstract Description Claims Application Information AI Technical Summary This helps you quickly interpret patents by identifying the three key elements: Problems solved by technology Method used Benefits of technology Problems solved by technology Since the synthesis of the polypeptide main chain mainly adopts the solid-phase method in the preparation process, a large amount of organic solvents are required, which is not friendly to the environment At the same time, this chemical synthesis method also has problems such as low yield and high cost in the preparation of long-chain polypeptides
